Mylan Sued Over Blood Pressure Drug

Law360, New York (June 4, 2008, 12:00 AM EDT) -- In a move to protect the market for the hypertension drug Azor, Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. on Tuesday hit Mylan Inc. with a patent infringement suit.

Daiichi Sankyo and its U.S.-based unit Daiichi Sankyo Inc. lodged the lawsuit in the U.S. District Court for the District of New Jersey against Mylan and its majority-owned subsidiary Matrix Laboratories Inc.

The Japanese company was responding to an abbreviated new drug application Matrix filed in early 2008 seeking the U.S. Food and Drug Administration's approval to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.